USFDA completes audit at Dr. Reddy’s API Hyderabad plant

16 Mar 2018 Evaluate

US Food and Drug Administration (USFDA) has completed audit at Dr. Reddy’s Laboratories’ API Hyderabad plant I at Jinnaram Mandal, Medak District, Telangana on March 16, 2018. USFDA has issued a Form 483 with four observations.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

5872.35 1.35 (0.02%)
15-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1528.20
Dr. Reddys Lab 5872.35
Cipla 1405.95
Zydus Lifesciences 997.45
Lupin 1638.40
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.